Skip to content

Momentus MNTS Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount

Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount at other companies

Momentus logo
MomentusMNTS
$29.25K
OS Therapies logo
OS TherapiesOSTX
$1.40
Alpha Cognition logo
Alpha CognitionACOG
164K
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-$750.5K
Apollo Global Management logo
Apollo Global ManagementAPO
2.6M
KULR Technology Group logo
KULR Technology GroupKULR
-$4.5

Other financials

Income statement

See full
Revenue$3.2M+898%
Gross profit$1.8M+464%
Operating income-$8.7M-40.5%
Net income-$9.5M-53.6%
EPS (diluted)-$2.15+92.7%

Balance sheet

See full
Cash & equivalents$23.6M+594%
Total debt$7.7M+832%
Total equity$27.2M+555%
Total assets$45.9M+291%

Cash flow

See full
Operating cash flow-$5.8M-39.3%
CapEx$197.0K
Free cash flow-$6.0M-44.0%

Valuation

See full
Market cap$111.32M+1,019%
Enterprise value$95.44M+806%
P/S27.8×+16.8×

Profitability

See full
Gross margin65%-31.5pp
Operating margin-743.5%-241pp
Net margin-843.8%-283pp
FCF margin-807.7%-232pp

Returns & leverage

See full
Return on equity-347.9%-1,002pp
Debt / equity0.3×
Current ratio2.5×+2.1×

Where this comes from

Reported directly by Momentus in its filing.

Tagged under the XBRL concept us-gaap:WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount.

The official record: Momentus’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Momentus's warrant down round feature decrease in net income loss to common shareholder amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Momentus's warrant down round feature decrease in net income loss to common shareholder amount?
Momentus (MNTS) reported warrant down round feature decrease in net income loss to common shareholder amount of $29.25K in Q4 2025.
What does warrant down round feature decrease in net income loss to common shareholder amount mean?
This metric quantifies the impact on net income attributable to common shareholders when the exercise price of existing warrants is reduced due to a down-round financing event. It reflects the accounting cost associated with the dilutive effect of adjusting warrant terms to protect investors during subsequent capital raises. This figure helps investors understand the magnitude of equity dilution and the financial burden imposed by anti-dilution provisions.